The Lawyer Africa Elite 2014 features an in-depth look at 46 leading independent firms’ strategies in 15 key sub-Saharan jurisdictions, as well as the views of in-house counsel from some of Africa’s largest companies... Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
Latham & Watkins has lost renowned M&A partner David Schwartzbaum to Greenberg Traurig in New York.
David Schwartzbaum was formerly head of Latham’s national office for M&A and also led the firm’s financial advisory practice.
His exit will be seen as a coup for Greenberg, a firm that has recently embarked on a particularly aggressive lateral hiring campaign on both sides of the Atlantic.
“Schwartzbaum’s a huge producer of work,” said one New York recruitment consultant. “He was an instrumental figure in Latham’s corporate practice.”
Schwartzbaum’s recent deals include advising CV Therapeutics in its $1.4bn (£870m) acquisition by Gilead; Axcan Pharma in its $1.3bn acquisition by an affiliate of Texas Pacific Group; and JPMorgan Partners in its $2.1bn going-private acquisition of AMC Entertainment.
His investment banking clients Bank of America-Merrill Lynch, Credit Suisse and Deutsche Bank.
Greenberg has made no secret of its ambition to grow its corporate practice. According to the recruiter: “It has the money to invest in it, is seeing other firms suffering and believes now is a good time to make a play”.
The firm’s recent hires include former Kirkland & Ellis restructuring specialist Lyndon Norley (30 November 2009), former Cadwalader Wickersham & Taft partners Bruce Zirinsky and John Bae (9 January 2009) and former Mayer Brown co-vice-chair Paul Maher.
A Latham spokesperson said the firm wished Schwartzbaum well.